Bayer Cropscience Share Price
Sector: Chemical Manufacturing
6065.00 +153.05 (2.59%)
- 1D
- 5D
- 1M
- 3M
- 6M
- 1Y
- 5Y
- MAX
Price Range
Today’s Low
5917.65
Today’s High
6171.00
52 Week Low
4220.05
52 Week High
7189.90
6114.00 +203.00 (3.43%)
- 1D
- 5D
- 1M
- 3M
- 6M
- 1Y
- 5Y
- MAX
Price Range
Today’s Low
5900.00
Today’s High
6187.00
52 Week Low
4217.45
52 Week High
7196.85
Key Metrics
- Market Cap (In Cr) 27296.39
- Beta 0.49
- Div. Yield (%) 2.11
- P/B 9.32
- TTM P/E 38.85
- Peg Ratio -11.23
- Sector P/E 18.02
- D/E 0
- Open Price 5963.95
- Prev Close 5911.95
Bayer Cropscience Analysis
Price Analysis
-
1 Week5.66%
-
3 Months25.54%
-
6 Month1.93%
-
YTD6.49%
-
1 Year-9.65%
Risk Meter
- 35% Low risk
- 35% Moderate risk
- 35% Balanced Risk
- 35% High risk
- 35% Extreme risk
Recos
- Strong Sell
- Sell
- Hold
- Buy
- Strong Buy
Analysts' Views
- Ratings
- Current
- 1 W Ago
- 1 M Ago
- 3 M Ago
- Strong Buy
- 0.00
- 0.00
- 1
- 1
- Buy
- 2
- 2
- 2
- 2
- Hold
- 5
- 5
- 3
- 3
- Sell
- 0.00
- 0.00
- 0.00
- 0.00
- Strong Sell
- 0.00
- 0.00
- 0.00
- 0.00
- Total
- 7
- 7
- 6
- 6
Bayer Cropscience News
Hero MotoCorp, Coromandel to Emami: Experts bullish on these stocks. Here's why
2 min read . 05 Jun 2025Eight stocks to buy for up to 15% gains on robust monsoon, strong economy
4 min read . 30 May 2025Bayer CropScience shares skyrocket 12% post Q4 Results, dividend announcement
1 min read . 27 May 2025Gillette India, KEC, Vadilal to PTC India: Seven stocks that declared dividend
2 min read . 27 May 2025Bayer Cropscience Financials
- INCOME
- BALANCE SHEET
- Cashflow
- Period
- 2025
- Total Revenue
- 5473.4
- Selling/ General/ Admin Expenses Total
- 449.8
- Depreciation/ Amortization
- 84.9
- Other Operating Expenses Total
- 935.2
- Total Operating Expense
- 4868.7
- Operating Income
- 604.7
- Net Income Before Taxes
- 707.4
- Net Income
- 568
- Diluted Normalized EPS
- 126.38
- Period
- 2025
- Total Assets
- 5245.9
- Total Liabilities
- 2395.5
- Total Equity
- 2850.4
- Tangible Book Valueper Share Common Eq
- 603.89
- Period
- 2025
- Cashfrom Operating Activities
- 262
- Cashfrom Investing Activities
- 85.6
- Cashfrom Financing Activities
- -619.4
- Net Changein Cash
- -271.8
- Period
- 2024
- Total Revenue
- 5103.2
- Selling/ General/ Admin Expenses Total
- 1127.8
- Depreciation/ Amortization
- 73.5
- Other Operating Expenses Total
- 29.7
- Total Operating Expense
- 4211.8
- Operating Income
- 891.4
- Net Income Before Taxes
- 941.4
- Net Income
- 740.5
- Diluted Normalized EPS
- 168.53
- Period
- 2024
- Total Assets
- 4597.1
- Total Liabilities
- 1747.7
- Total Equity
- 2849.4
- Tangible Book Valueper Share Common Eq
- 606.11
- Period
- 2024
- Cashfrom Operating Activities
- 951.6
- Cashfrom Investing Activities
- 0.4
- Cashfrom Financing Activities
- -656.3
- Net Changein Cash
- 295.7
- Period
- 2023
- Total Revenue
- 5139.7
- Selling/ General/ Admin Expenses Total
- 1305.2
- Depreciation/ Amortization
- 79
- Other Operating Expenses Total
- 33.2
- Total Operating Expense
- 4181.3
- Operating Income
- 958.4
- Net Income Before Taxes
- 990.1
- Net Income
- 758.2
- Diluted Normalized EPS
- 150.95
- Period
- 2023
- Total Assets
- 4678.6
- Total Liabilities
- 1966.5
- Total Equity
- 2712.1
- Tangible Book Valueper Share Common Eq
- 577.94
- Period
- 2023
- Cashfrom Operating Activities
- 609.3
- Cashfrom Investing Activities
- 83.3
- Cashfrom Financing Activities
- -613.2
- Net Changein Cash
- 79.4
- Period
- 2022
- Total Revenue
- 4734.4
- Selling/ General/ Admin Expenses Total
- 1187.1
- Depreciation/ Amortization
- 64
- Other Operating Expenses Total
- 25.6
- Total Operating Expense
- 3918.7
- Operating Income
- 815.7
- Net Income Before Taxes
- 846.8
- Net Income
- 645.3
- Diluted Normalized EPS
- 133.87
- Period
- 2022
- Total Assets
- 4352.9
- Total Liabilities
- 1828.6
- Total Equity
- 2524.3
- Tangible Book Valueper Share Common Eq
- 541.81
- Period
- 2022
- Cashfrom Operating Activities
- 215.5
- Cashfrom Investing Activities
- 64.2
- Cashfrom Financing Activities
- -703.3
- Net Changein Cash
- -423.6
- Period
- 2021
- Total Revenue
- 4261.3
- Selling/ General/ Admin Expenses Total
- 942.5
- Depreciation/ Amortization
- 73
- Other Operating Expenses Total
- 18.1
- Total Operating Expense
- 3507.3
- Operating Income
- 754
- Net Income Before Taxes
- 794.5
- Net Income
- 493.1
- Diluted Normalized EPS
- 108.19
- Period
- 2021
- Total Assets
- 4239.3
- Total Liabilities
- 1689
- Total Equity
- 2550.3
- Tangible Book Valueper Share Common Eq
- 551.84
- Period
- 2021
- Cashfrom Operating Activities
- 686.7
- Cashfrom Investing Activities
- 6.7
- Cashfrom Financing Activities
- -555.8
- Net Changein Cash
- 137.6
- Period
- 2020
- Total Revenue
- 3609.4
- Selling/ General/ Admin Expenses Total
- 921.1
- Depreciation/ Amortization
- 64.9
- Other Operating Expenses Total
- 11
- Total Operating Expense
- 3068.3
- Operating Income
- 541.1
- Net Income Before Taxes
- 583.1
- Net Income
- 474.5
- Diluted Normalized EPS
- 127.94
- Period
- 2020
- Total Assets
- 3835.7
- Total Liabilities
- 1263.2
- Total Equity
- 2572.5
- Tangible Book Valueper Share Common Eq
- 560.39
- Period
- 2020
- Cashfrom Operating Activities
- 665.9
- Cashfrom Investing Activities
- -28.9
- Cashfrom Financing Activities
- -148.3
- Net Changein Cash
- 488.7
- Period
- 2019
- Total Revenue
- 3167.3
- Selling/ General/ Admin Expenses Total
- 970.9
- Depreciation/ Amortization
- 43.2
- Other Operating Expenses Total
- 13.5
- Total Operating Expense
- 2710.4
- Operating Income
- 456.9
- Net Income Before Taxes
- 480
- Net Income
- 337.1
- Diluted Normalized EPS
- 99.84
- Period
- 2019
- Total Assets
- 3549.2
- Total Liabilities
- 1309.8
- Total Equity
- 2239.4
- Tangible Book Valueper Share Common Eq
- 639.84
- Period
- 2019
- Cashfrom Operating Activities
- 734.6
- Cashfrom Investing Activities
- -414.7
- Cashfrom Financing Activities
- -158.3
- Net Changein Cash
- 161.6
- Period
- 2025-03-31
- Total Revenue
- 1046.4
- Selling/ General/ Admin Expenses Total
- 111.2
- Depreciation/ Amortization
- 34.3
- Other Operating Expenses Total
- 200.3
- Total Operating Expense
- 909.9
- Operating Income
- 136.5
- Net Income Before Taxes
- 167.9
- Net Income
- 143.3
- Diluted Normalized EPS
- 31.88
- Period
- 2025-03-31
- Total Assets
- 5245.9
- Total Liabilities
- 2395.5
- Total Equity
- 2850.4
- Tangible Book Valueper Share Common Eq
- 603.89
- Period
- 2025-03-31
- Cashfrom Operating Activities
- 262
- Cashfrom Investing Activities
- 85.6
- Cashfrom Financing Activities
- -619.4
- Net Changein Cash
- -271.8
- Period
- 2024-12-31
- Total Revenue
- 1056.9
- Selling/ General/ Admin Expenses Total
- 123.1
- Depreciation/ Amortization
- 15.1
- Other Operating Expenses Total
- 255.8
- Total Operating Expense
- 1052.3
- Operating Income
- 4.6
- Net Income Before Taxes
- 33.6
- Net Income
- 34.2
- Diluted Normalized EPS
- 7.61
- Period
- 2024-12-31
- Period
- 2024-12-31
- Period
- 2024-09-30
- Total Revenue
- 1737.6
- Selling/ General/ Admin Expenses Total
- 115.9
- Depreciation/ Amortization
- 14
- Other Operating Expenses Total
- 246
- Total Operating Expense
- 1567.8
- Operating Income
- 169.8
- Net Income Before Taxes
- 190.1
- Net Income
- 136.3
- Diluted Normalized EPS
- 30.33
- Period
- 2024-09-30
- Total Assets
- 5270.5
- Total Liabilities
- 2188.3
- Total Equity
- 3082.2
- Tangible Book Valueper Share Common Eq
- 656.42
- Period
- 2024-09-30
- Cashfrom Operating Activities
- -85.6
- Cashfrom Investing Activities
- 18.2
- Cashfrom Financing Activities
- -178.9
- Net Changein Cash
- -246.3
- Period
- 2024-06-30
- Total Revenue
- 1631.2
- Selling/ General/ Admin Expenses Total
- 99.6
- Depreciation/ Amortization
- 21.5
- Other Operating Expenses Total
- 233.1
- Total Operating Expense
- 1338.7
- Operating Income
- 292.5
- Net Income Before Taxes
- 315.8
- Net Income
- 254.2
- Diluted Normalized EPS
- 56.56
- Period
- 2024-06-30
- Period
- 2024-06-30
- Period
- 2024-03-31
- Total Revenue
- 791.5
- Selling/ General/ Admin Expenses Total
- 302.6
- Depreciation/ Amortization
- 15.9
- Total Operating Expense
- 710.8
- Operating Income
- 80.7
- Net Income Before Taxes
- 105.4
- Net Income
- 96
- Diluted Normalized EPS
- 24.5
- Period
- 2024-03-31
- Total Assets
- 4597.1
- Total Liabilities
- 1747.7
- Total Equity
- 2849.4
- Tangible Book Valueper Share Common Eq
- 606.11
- Period
- 2024-03-31
- Cashfrom Operating Activities
- 951.6
- Cashfrom Investing Activities
- 0.4
- Cashfrom Financing Activities
- -656.3
- Net Changein Cash
- 295.7
- Period
- 2023-12-31
- Total Revenue
- 954.9
- Selling/ General/ Admin Expenses Total
- 113.9
- Depreciation/ Amortization
- 15.2
- Other Operating Expenses Total
- 184.7
- Total Operating Expense
- 842.2
- Operating Income
- 112.7
- Net Income Before Taxes
- 124.2
- Net Income
- 93.1
- Diluted Normalized EPS
- 20.72
- Period
- 2023-12-31
- Period
- 2023-12-31
Forecast
Income Sheet (In Cr)
Net Income Vs Revenue
Returns Metrics (In Cr)
ROA Vs ROE
Forecast
Balance Sheet
Asset vs Liability
Forecast
Cash Flow
Operating vs Investing
Bayer Cropscience Technical
Moving Average
SMA
- 5 Day5609.14
- 10 Day5570.02
- 20 Day5565.65
- 50 Day5183.18
- 100 Day5006.16
- 300 Day5550.71
Bayer Cropscience Peers
- Price
- Ratio
- Name
- Latest Price
- Change
- % Change
- 52W High
- 52W Low
- Mkt. Cap
- 3m India
- 28585.5
- -38.95
- -0.14
- 41000
- 25714.35
- 32139.39
- Deepak Nitrite
- 1981.25
- 12.25
- 0.62
- 3168.65
- 1780.5
- 27084.77
- Bayer Cropscience
- 6065
- 153.05
- 2.59
- 7189.9
- 4220.05
- 27296.39
- Sumitomo Chemical India
- 521.05
- 5.85
- 1.14
- 628
- 446.7
- 25967.67
- Tata Chemicals
- 934.6
- -0.45
- -0.05
- 1244.7
- 756.45
- 23836.29
- Name
- P/E (X)
- P/B (X)
- ROE %
- OPM
- 3m India
- 67.44
- 17.39
- 20.02
- 10.49
- Deepak Nitrite
- 38.04
- 4.92
- 23.28
- 11.97
- Bayer Cropscience
- 45.5
- 9.07
- 24.01
- 12.97
- Sumitomo Chemical India
- 50.5
- 8.8
- 20.73
- 14.12
- Tata Chemicals
- 82.87
- 1.11
- 4.72
- 7.28
Bayer Cropscience Shareholding
Shareholding Pattern
Shareholding Trend
Shareholding(%) v/s Date
Corporate Actions
- Board Meeting
- AGM
- Dividends
- Bonus
- Split
- Rights
- Meeting Date
- Purpose
- 26-May-25
- Audited Results & Final Dividend
- 11-Feb-25
- Quarterly Results
- 13-Nov-24
- Quarterly Results
- 08-Aug-24
- Quarterly Results
- 23-May-24
- Audited Results & Final Dividend
- 01-Feb-24
- Quarterly Results
- 03-Nov-23
- Quarterly Results & Interim Dividend
- 07-Aug-23
- Quarterly Results
- 24-May-23
- Audited Results & Final Dividend
- 07-Feb-23
- Quarterly Results
- Meeting Date
- Announced on
- Purpose
- 04-Apr-25
- 24-Feb-25
- POM
- 14-Aug-24
- 02-Jul-24
- AGM
- 27-Mar-24
- 23-Feb-24
- POM
- 05-Jan-24
- 30-Nov-23
- POM
- 17-Aug-23
- 04-Jul-23
- AGM
- 22-Mar-22
- 15-Feb-22
- POM
- 12-Aug-21
- 07-Jul-21
- AGM
- Announced on
- Record Date
- Ex-Dividend
- Dividend Value
- 26-May-25
- -
- -
- 35
- 14-Nov-24
- 28-Nov-24
- 28-Nov-24
- 90
- 23-May-24
- -
- 01-Aug-24
- 35
- 03-Nov-23
- 16-Nov-23
- 16-Nov-23
- 105
- 24-May-23
- -
- 04-Aug-23
- 30
- 09-Nov-22
- 19-Nov-22
- 17-Nov-22
- 100
- 24-May-22
- -
- 04-Aug-22
- 25
- 01-Nov-21
- 13-Nov-21
- 11-Nov-21
- 125
- 25-May-21
- -
- 27-Jul-21
- 25


